PharmiWeb.com - Global Pharma News & Resources

Crescendo Biologics

Research & Development

Crescendo Biologics (Crescendo) is a clinical stage company, focused on transforming the lives of cancer patients through its pipeline of novel, T cell enhancing therapies. The lead programme, CB307, is a first in class PSMA x CD137 (4-1BB) bispecific molecule.